Νέα θεραπεία από γιατρό

[JimKan1]

Μονιμες παρενεργειες δεν υφιστανται, ή τουλαχιστον κατι τετοιο τοσα χρονια δεν εχει αναφερθει επισημα πουθενα. Καμια επιστημονικη τεκμηριωση του προβληματος, π.χ. με εξετασεις που αποδεικνυουν οτι οντως κατι υπολειτουργει.

Τι εννοεις που αποδυκνειουν οτι κατι υπολειτουργει; δεν εχουν βρεθει τα αιτια για ολες τις ανθρωπινες παθησεις, εννοεις οτι για τις παθησεις που δεν εχουν βρεθει τα αιτια ειναι στο μυαλο μας;

Οσον αφορα τις μονιμες παρενεργειες απο την φινα και αν εχουν αναφερθει επισημα μπορεις να ριξεις μια ματια στα παρακατω

5α-Reductase Inhibitors - StatPearls - NCBI Bookshelf

Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride - PubMed

Risk of PED was higher in men with longer exposure to 5α-RIs. Among young men, longer exposure to finasteride posed a greater risk of PED than all other assessed risk factors.

pubmed.ncbi.nlm.nih.gov

An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia - PubMed

Concern regarding adverse effects of finasteride is increasing. We aimed to determine the type and frequency of symptoms in men having long-term sexual and non-sexual side effects after finasteride treatment (a condition recently called post-finasteride syndrome, PFS) against androgenetic...

pubmed.ncbi.nlm.nih.gov

Post-finasteride syndrome: An emerging clinical problem - PubMed

The presence of side effects during pharmacological treatment is unfortunately a quite common problem. In this review, we focused our attention on adverse events related to 5 alpha-reductase (5α-R) inhibitors (i.e., finasteride and dutasteride), approved for the treatment of benign prostatic...

pubmed.ncbi.nlm.nih.gov

Post-finasteride syndrome: a surmountable challenge for clinicians - PubMed

Post-finasteride syndrome (PFS) is a constellation of serious adverse side effects manifested in clinical symptoms that develop and persist in patients during and/or after discontinuing finasteride treatment in men with pattern hair loss (androgenetic alopecia) or benign prostatic hyperplasia...

pubmed.ncbi.nlm.nih.gov

Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients - PubMed

PFS, commonly observed in young men, has certain clinical manifestations, mainly psychological disorders and abnormal sexual functions. Young men who may take finasteride therapy for hair loss should receive consultation services and be informed of possible future harms. Psychological screening...

pubmed.ncbi.nlm.nih.gov

Post-finasteride syndrome - PMC

Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects. Recently there ...

www.ncbi.nlm.nih.gov

 

[Thanos92]

Σιγουρα δεν ειναι ηπιο, ακομα και για Σ.Δ. αν δεις τον αλγοριθμο δεν ειναι στις πρωτες επιλογες. Περισσοτερο παιζει σε πιτυριαση στο σωμα πλεον.
Οπως και να χει ομως ειναι απο τις λιγες ουσιες που τουλαχιστον εχουν και μια βιβλιογραφια. Αρα αν καποιος θελει οπωσδηποτε σαμπουαν τριχοπτωσης, το δοκιμαζει. Και τα καφεινης φαινεται να βοηθουν. Βεβαια τιποτα απο αυτα δεν ειναι σαν τη φιναστεριδη και τη μινοξιδιλη.

Εγώ έχω ένα μίξ ξηροδερμίας και Σ.Δ αλλα επειδή έχω σγουρό μαλλί, αν βάλω 3 φορές την εβδομάδα κετο, το μαλλι μου σε ένα μήνα θα είναι σαν σήρμα. Παλιά που το έβαζα ανα διαστήματα είχα θέμα και πολλές φορές μου αφυδάτωνε τόσο το τριχωτό που έκανε πιο έντονη την ξηροδερμία. Ίσως για μία φορά την εβδομάδα να το ξανα αρχίσω, αλλά δεν ξέρω αν 1 φορά είναι αρκετη για να βοηθήσει στη θεραπεία της τριχόπτωσης.

 

[Kostas97]

Τι εννοεις που αποδυκνειουν οτι κατι υπολειτουργει; δεν εχουν βρεθει τα αιτια για ολες τις ανθρωπινες παθησεις, εννοεις οτι για τις παθησεις που δεν εχουν βρεθει τα αιτια ειναι στο μυαλο μας;

Οσον αφορα τις μονιμες παρενεργειες απο την φινα και αν εχουν αναφερθει επισημα μπορεις να ριξεις μια ματια στα παρακατω

5α-Reductase Inhibitors - StatPearls - NCBI Bookshelf

Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride - PubMed

Risk of PED was higher in men with longer exposure to 5α-RIs. Among young men, longer exposure to finasteride posed a greater risk of PED than all other assessed risk factors.

pubmed.ncbi.nlm.nih.gov

An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia - PubMed

Concern regarding adverse effects of finasteride is increasing. We aimed to determine the type and frequency of symptoms in men having long-term sexual and non-sexual side effects after finasteride treatment (a condition recently called post-finasteride syndrome, PFS) against androgenetic...

pubmed.ncbi.nlm.nih.gov

Post-finasteride syndrome: An emerging clinical problem - PubMed

The presence of side effects during pharmacological treatment is unfortunately a quite common problem. In this review, we focused our attention on adverse events related to 5 alpha-reductase (5α-R) inhibitors (i.e., finasteride and dutasteride), approved for the treatment of benign prostatic...

pubmed.ncbi.nlm.nih.gov

Post-finasteride syndrome: a surmountable challenge for clinicians - PubMed

Post-finasteride syndrome (PFS) is a constellation of serious adverse side effects manifested in clinical symptoms that develop and persist in patients during and/or after discontinuing finasteride treatment in men with pattern hair loss (androgenetic alopecia) or benign prostatic hyperplasia...

pubmed.ncbi.nlm.nih.gov

Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients - PubMed

PFS, commonly observed in young men, has certain clinical manifestations, mainly psychological disorders and abnormal sexual functions. Young men who may take finasteride therapy for hair loss should receive consultation services and be informed of possible future harms. Psychological screening...

pubmed.ncbi.nlm.nih.gov

Post-finasteride syndrome - PMC

Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects. Recently there ...

www.ncbi.nlm.nih.gov

Ολες οι αναφορες ειναι long term/persistent adverse side effects.
Ολες οι αναφορες αφορουν αυτο-εξεταση. Για εμενα δεν εχει καμια επιστημονικη τεκμηριωση ολο αυτο.
Βεβαια ο καθενας μπορει να το πιστευει ελευθερα.

 

[Vdupa]

Τι εννοεις που αποδυκνειουν οτι κατι υπολειτουργει; δεν εχουν βρεθει τα αιτια για ολες τις ανθρωπινες παθησεις, εννοεις οτι για τις παθησεις που δεν εχουν βρεθει τα αιτια ειναι στο μυαλο μας;

Οσον αφορα τις μονιμες παρενεργειες απο την φινα και αν εχουν αναφερθει επισημα μπορεις να ριξεις μια ματια στα παρακατω

5α-Reductase Inhibitors - StatPearls - NCBI Bookshelf

Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride - PubMed

Risk of PED was higher in men with longer exposure to 5α-RIs. Among young men, longer exposure to finasteride posed a greater risk of PED than all other assessed risk factors.

pubmed.ncbi.nlm.nih.gov

An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia - PubMed

Concern regarding adverse effects of finasteride is increasing. We aimed to determine the type and frequency of symptoms in men having long-term sexual and non-sexual side effects after finasteride treatment (a condition recently called post-finasteride syndrome, PFS) against androgenetic...

pubmed.ncbi.nlm.nih.gov

Post-finasteride syndrome: An emerging clinical problem - PubMed

The presence of side effects during pharmacological treatment is unfortunately a quite common problem. In this review, we focused our attention on adverse events related to 5 alpha-reductase (5α-R) inhibitors (i.e., finasteride and dutasteride), approved for the treatment of benign prostatic...

pubmed.ncbi.nlm.nih.gov

Post-finasteride syndrome: a surmountable challenge for clinicians - PubMed

Post-finasteride syndrome (PFS) is a constellation of serious adverse side effects manifested in clinical symptoms that develop and persist in patients during and/or after discontinuing finasteride treatment in men with pattern hair loss (androgenetic alopecia) or benign prostatic hyperplasia...

pubmed.ncbi.nlm.nih.gov

Case report: a study of the clinical characteristics and genetic variants of post-finasteride syndrome patients - PubMed

PFS, commonly observed in young men, has certain clinical manifestations, mainly psychological disorders and abnormal sexual functions. Young men who may take finasteride therapy for hair loss should receive consultation services and be informed of possible future harms. Psychological screening...

pubmed.ncbi.nlm.nih.gov

Post-finasteride syndrome - PMC

Finasteride is a 5α-reductase enzyme inhibitor that has been approved for the treatment of male androgenic alopecia since 1997. Over time, it has been considered a safe and well-tolerated drug with rare and reversible side effects. Recently there ...

www.ncbi.nlm.nih.gov

Θα κρατησω την τελευταια που ειναι το 2020 και μιλάει για την συνολική εικόνα.

Studies to date cannot refute or confirm this syndrome as a nosological entity.
If it actually exists, it seems to occur in susceptible people, even if exposed to small doses and for short periods, and symptoms may persist for long periods.

Το οτι γίνονται ερευνες για το θεμα, δεν σημαινει οτι εχουν καταλήξει σε ένα συμπέρασμα.
Να θυμίσω οτι στα control group (δηλαδη σε αυτα που δεν παιρνουν το χαπι) βγαζουν σεξουαλικες παρενεργειες μεχρι και γυναικομαστία.

 

[JimKan1]

Θα κρατησω την τελευταια που ειναι το 2020 και μιλάει για την συνολική εικόνα.

Studies to date cannot refute or confirm this syndrome as a nosological entity.
If it actually exists, it seems to occur in susceptible people, even if exposed to small doses and for short periods, and symptoms may persist for long periods.

Το οτι γίνονται ερευνες για το θεμα, δεν σημαινει οτι εχουν καταλήξει σε ένα συμπέρασμα.
Να θυμίσω οτι στα control group (δηλαδη σε αυτα που δεν παιρνουν το χαπι) βγαζουν σεξουαλικες παρενεργειες μεχρι και γυναικομαστία.

το αν ειναι πραγματικη η οχι ειναι αλλη συζητηση, το ζητημα ειναι αν υπαρχει επισημη αναφορα, ανοιγοντας το δευτερο λινκ μπορεις να δεις αυτο εδω.